ArticleThe journal of prevention of Alzheimer's disease2026

Class-level aggregation obscures clinically relevant heterogeneity in anti-amyloid antibody trials: comments on a Cochrane review by individual members of the EADC.

Kristian Steen Frederiksen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.